Invention Grant
- Patent Title: Pyrrolobenzodiazepine-antibody conjugates
-
Application No.: US15529622Application Date: 2015-11-25
-
Publication No.: US10780096B2Publication Date: 2020-09-22
- Inventor: Patricius Henrikus Cornelis Van Berkel , Philip Wilson Howard , John Hartley
- Applicant: ADC THERAPEUTICS SA , MEDIMMUNE LIMITED
- Applicant Address: CH Epalinges GB Cambridge, Cambridgesh
- Assignee: ADC THERAPEUTICS SA,MEDIMMUNE LIMITED
- Current Assignee: ADC THERAPEUTICS SA,MEDIMMUNE LIMITED
- Current Assignee Address: CH Epalinges GB Cambridge, Cambridgesh
- Agency: Casimir Jones, S.C.
- Agent Melissa E. Kolom
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@e9ff31c com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6255bc05
- International Application: PCT/EP2015/077684 WO 20151125
- International Announcement: WO2016/083468 WO 20160602
- Main IPC: A61K31/5517
- IPC: A61K31/5517 ; A61K47/68 ; C07K16/28
Abstract:
The present disclosure relates to the use of antibody-drug conjugates (ADCs) comprising pyrrolobenzodiazepine (PBD) dimers and anti-CD25 antibodies for use in treating disorders characterized by the presence of CD25+ve cells.
Public/Granted literature
- US20170258934A1 PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES Public/Granted day:2017-09-14
Information query
IPC分类:
